Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clear-cell adenocarcinoma of vesical origin: a case study of metastatic disease treated with chemotherapy.
Pena Álvarez C, Lorenzo Lorenzo I, Varela Ferreiro S, Pardavila Gómez R, Suh Oh HJ, Saénz de Miera Rodríguez A, Covela Rúa M, Carbonell Luyo WF, García Arroyo FR, López Clemente P, Palacios Ozores P, Constenla Figueiras M. Pena Álvarez C, et al. Among authors: constenla figueiras m. Chemother Res Pract. 2010;2010:426973. doi: 10.1155/2010/426973. Epub 2010 Oct 17. Chemother Res Pract. 2010. PMID: 22482051 Free PMC article.
Interstitial lung disease associated with oxaliplatin: description of two cases.
Pena Alvarez C, Suh Oh HJ, Sáenz de Miera Rodríguez A, García Arroyo FR, Covela Rúa M, Salgado Boquete L, López Clemente PM, Constenla Figueiras M. Pena Alvarez C, et al. Among authors: constenla figueiras m. Clin Transl Oncol. 2009 May;11(5):332-3. doi: 10.1007/s12094-009-0364-4. Clin Transl Oncol. 2009. PMID: 19451069 No abstract available.
Spanish Society of Medical Oncology consensus for the use of haematopoietic colony-stimulating factors in cancer patients.
Carrato A, Paz-Ares Rodríguez L, Rodríguez Lescure A, Casas Fernández de Tejerina AM, Díaz Rubio García E, Pérez Segura P, Constenla Figueiras M, García Carbonero R, Gómez Codina J, Lluch Hernández A, Maroto Rey JP, Martín Jiménez M, Mayordomo Cámara JI, Moreno Nogueira JA, Rueda Domínguez A; Spanish Society of Medical Oncology (SEOM). Carrato A, et al. Among authors: constenla figueiras m. Clin Transl Oncol. 2009 Jul;11(7):446-54. doi: 10.1007/s12094-009-0383-1. Clin Transl Oncol. 2009. PMID: 19574202
Cutaneous adverse events and quality of life in outpatients receiving anticancer agents: results from an observational, cross-sectional study.
Suh Oh HJ, Flórez Menéndez Á, Sacristán Santos V, Fernández Ribeiro F, Vilanova-Trillo L, Constenla Figueiras M, Pereiro Ferreiros M. Suh Oh HJ, et al. Among authors: constenla figueiras m. Drugs Context. 2020 Aug 5;9:2020-6-6. doi: 10.7573/dic.2020-6-6. eCollection 2020. Drugs Context. 2020. PMID: 32821263 Free PMC article.
Spanish Society of Medical Oncology consensus on the use of erythropoietic stimulating agents in anaemic cancer patients.
Alberola Candel V, Carrato Mena A, Díaz-Rubio García E, Gascón Vilaplana P, González Barón M, Martín Jiménez M, Alba Conejo E, Cassinello Espinosa J, Colomer R, Cruz Hernández JJ, Barnadas i Molins A, Camps Herrero C, Casas Fernández de Tejerina AM, Carulla Torrent J, Constenla Figueiras M, Gavilá Gregori J, Isla Casado MD, Massuti Sureda B, Provencio Pulla M, Rodríguez Sánchez CA, Sanz Ortiz J; Spanish Society of Medical Oncology. Alberola Candel V, et al. Among authors: constenla figueiras m. Clin Transl Oncol. 2009 Nov;11(11):727-36. doi: 10.1007/s12094-009-0435-6. Clin Transl Oncol. 2009. PMID: 19917536
Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E, Constenla Figueiras M, Cortes-Funes H, Diaz-Rubio García E, Gascon Vilaplana P, Guillém V, Martin-Algarra S. Aranda Aguilar E, et al. Among authors: constenla figueiras m. Expert Rev Anticancer Ther. 2005 Dec;5(6):963-72. doi: 10.1586/14737140.5.6.963. Expert Rev Anticancer Ther. 2005. PMID: 16336087 Review.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
PETACC-8 study investigators; Thaler J, Greil R, Gaenzer J, Eisterer W, Tschmelitsch J, Samonigg H, Zabernigg A, Schmid F, Steger G, Steinacher R, Andel J, Lang A, Függer R, Hofbauer F, Woell E, Geissler D, Lenauer A, Prager M, Van Laethem JL, Van Cutsem E, D'Haens G, Demolin G, Kerger J, Deboever G, Ghillebert G, Polus M, Van Cutsem E, RezaieKalantari H, Delaunoit T, Goeminne JC, Peeters M, Vergauwe P, Houbiers G, Humblet Y, Janssens J, Schrijvers D, Vanderstraeten E, Van Laethem JL, Vermorken J, Van Daele D, Ferrante M, Forget F, Hendlisz A, Yilmaz M, Nielsen SE, Vestermark L, Larsen J, Ychou M, Zawadi A, Zawadi MA, Bouche O, Mineur L, Bennouna-Louridi J, Dourthe LM, Ychou M, Boucher E, Taieb J, Pezet D, Desseigne F, Ducreux M, Texereau P, Miglianico L, Rougier P, Fratte S, Levache CB, Merrouche Y, Ellis S, Locher C, Ramee JF, Garnier C, Viret F, Chauffert B, Cojean-Zelek I, Michel P, Lecaille C, Borel C, Seitz JF, Smith D, Lombard-Bohas C, Andre T, Gornet JM, Fein F, Coulon-Sfairi MA, Kaminsky MC, Lagasse JP, Luet D, Etienne PL, Gasmi M, Vanoli A, Nguyen S, Aparicio T, Perrier H, Stremsdoerfer N, Laplaige P, Arsene D, Auby D, Bedenne L, Coriat R, Denis B, Geoffroy P, Piot G, Be… See abstract for full author list ➔ PETACC-8 study investigators, et al. Ann Oncol. 2015 Apr;26(4):822-825. doi: 10.1093/annonc/mdv070. Ann Oncol. 2015. PMID: 25814651 Free article. No abstract available.
Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial.
Taieb J, Tabernero J, Mini E, Subtil F, Folprecht G, Van Laethem JL, Thaler J, Bridgewater J, Petersen LN, Blons H, Collette L, Van Cutsem E, Rougier P, Salazar R, Bedenne L, Emile JF, Laurent-Puig P, Lepage C; PETACC-8 Study Investigators. Taieb J, et al. Lancet Oncol. 2014 Jul;15(8):862-73. doi: 10.1016/S1470-2045(14)70227-X. Epub 2014 Jun 11. Lancet Oncol. 2014. PMID: 24928083 Free article. Clinical Trial.